Futura Medical to Present on new Impedance Testing Data for MED2005 for the Treatment of Erectile Dysfunction at the 21st ESSM Congress and Host Advisory Meeting

Futura Medical plc (AIM: FUM) (the “Company”), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, today announces that it will be presenting at the 21st Congress of the ESSM, on 14-16 February 2019, at Cultural and Congress Centre Cankarjev Dom, Ljubljana, Slovenia.

Futura’s presentation will include new safety data relevant to sexual partners on its lead product MED2005, a topical glyceryl trinitrate (“GTN”) gel for the treatment of erectile dysfunction (“ED”). Futura will also host its second Scientific Advisory Meeting in Slovenia with high profile European Key Opinion Leaders (“KOLs”) in the field of ED.

Tim Holland, Director of Clinical Development at Futura Medical, will be presenting a poster entitled “Establishing the safety profile in sexual partners of a new topical glyceryl trinitrate gel for the treatment of erectile dysfunction” on Thursday 14 February at 15.30 CET. The presentation will be part of the “Male sexual dysfunction: medical treatment” poster session held in Foyer 1, Floor 1

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...